Annovis Bio, Inc. (ANVS) Misses Q3 EPS by 46c
Annovis Bio, Inc. (NYSE: ANVS) reported Q3 EPS of ($0.97), $0.46 worse than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Annovis Bio, Inc. (ANVS) click here.
Annovis Bio, Inc. (NYSE: ANVS) reported Q3 EPS of ($0.97), $0.46 worse than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Annovis Bio, Inc. (ANVS) click here.